Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Relapsed or refractory Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma prior to autologous stem cell transplant.
Approved for use in oncology care according to FDA-approved indications.
Treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant.
Targeted treatment of solid tumors and hematologic malignancies.
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma, Waldenström's Macroglobulinemia.
Philadelphia chromosome-positive Chronic Myeloid Leukemia (Ph+ CML) and Ph+ Acute Lymphoblastic Leukemia (ALL).
Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.
Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.
Relapsed or refractory B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma, or Multiple Myeloma.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
Brain Tumors (Glioblastoma, Astrocytoma), Multiple Myeloma, Lymphomas, Leukemias, Sarcomas, and conditioning regimens.